TABLE 1.
Description of the patient cohort. Percentages of distant recurrences are calculated with respect to the number of patients within corresponding category.
| Parameter | Number (n = 109) | Distant recurrence |
|---|---|---|
| Age | ||
| ≤50 | 29 (26.6%) | 3 (10.3%) |
| >50 | 80 (73.4%) | 6 (7.5%) |
| Tumor size | ||
| T1 | 76 (69.7%) | 4 (5.3%) |
| T2 | 33 (30.3%) | 5 (15.2%) |
| Grade | ||
| 1 | 22 (20.2%) | 2 (9.1%) |
| 2 | 68 (62.4%) | 5 (7.4%) |
| 3 | 19 (17.4%) | 2 (10.5%) |
| Node status | ||
| N0 | 93 (85.3%) | 7 (7.5%) |
| N1 | 15 (13.8%) | 2 (13.3%) |
| N2 | 1 (0.9%) | 0 (0%) |
| Therapy | ||
| Endocrine therapy alone | 76 (69.7%) | 7 (9.2%) |
| Endocrine therapy + Chemotherapy | 33 (30.3%) | 2 (6.1%) |
| Distant recurrence | ||
| No recurrence | 100 (91.7%) | N.A. |
| Recurrence | 9 (8.3%) | N.A. |